Perspectives and challenges of small molecule inhibitor therapy for FLT3-mutated acute myeloid leukemia
Crossref DOI link: https://doi.org/10.1007/s00277-023-05545-3
Published Online: 2023-11-17
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lap, Coen J
Abrahim, Marwa SH
Nassereddine, Samah http://orcid.org/0000-0001-5294-0545
Text and Data Mining valid from 2023-11-17
Version of Record valid from 2023-11-17
Article History
Received: 12 September 2023
Accepted: 6 November 2023
First Online: 17 November 2023
Declarations
:
: The authors declare no competing interests.